Stocks · News reference
8-K filing — Nexalin Technology, Inc. (NXL)
Filed: 2026-08-21 AccNo: 0001829126-26-009226 Size: 389 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 9.01: Financial Statements and Exhibits
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- edgar
- Observed
- Aug 21, 2026, 9:20 PM
- Checked
- Aug 21, 2026, 9:20 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
8-K filing — Nexalin Technology, Inc. (NXL)
Filed: 2026-08-27 AccNo: 0001829126-26-009387 Size: 241 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarNexalin Technology Announces 1-For-30 Reverse Stock Split, Effective August 28
Read original at benzingaNexalin Technology To Present Clinical Data Showing 77.8% Anxiety Response Rate, Durable 8-Week Benefits, And No Serious Adverse Events From Its 15 mA, 77.5 Hz DIFS Deep-Brain Stimulation Platform, At 2026 NYC Neuromodulation Conference
Read original at benzinga